TL;DR: Noom grew from $12M ARR in 2017 to an estimated $1B ARR in 2023, finding product-market fit by combining WeightWatchers' coaching model with the mobile-native food and activity tracking of MyFitnessPal. Now, Noom is selling generic Ozempic and going up against multi-vertical telehealth companies like Ro and Hims & Hers. For more, check out our full report and dataset on Noom...